会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 131. 发明授权
    • Ultrasound enhancement of transbuccal drug delivery
    • 超声提高了跨颊药物的输送
    • US4948587A
    • 1990-08-14
    • US233590
    • 1988-08-18
    • Joseph KostRobert S. Langer
    • Joseph KostRobert S. Langer
    • A61K9/00A61K41/00A61M35/00A61M37/00
    • A61K41/0047A61K9/0009A61M37/00A61M37/0092A61M35/00
    • A method using ultrasound for enhancing and controlling transbuccal permeation of a molecule, including drugs, antigens, vitamins, inorganic and organic compounds, and various combinations of these substances, through the buccal membranes and into the circulatory system. The frequency and intensity of ultrasonic energy which is applied, and the length of time of exposure are determined according to the location and nature of the buccal membrane and the substance to be infused. Levels of the infused molecules in the blood and urine measured over a period of time are initially used to determine under what conditions optimum transfer occurs. In a variation of the method, whereby ultrasound is applied directly to the compound and site where the compound is to be infused through the buccal membranes, the compound can be placed within a delivery device. In one variation, the ultrasound can control release both by direct interaction with the compound and membrane but also with the delivery device. In another variation, the delivery device helps to modulate release and infusion rate. The compound can also be administered in combination with a chemical agent which alters permeability of the buccal membrane, thereby aiding infusion of the compound into the circulatory system.
    • 一种使用超声波增强和控制分子(包括药物,抗原,维生素,无机和有机化合物)以及这些物质的各种组合的跨颊渗透通过颊膜进入循环系统的方法。 应用超声能量的频率和强度以及暴露时间长短根据颊膜和待注射物质的位置和性质来确定。 在一段时间内测量的血液和尿液中输注的分子的水平最初用于确定什么条件下最佳转移发生。 在该方法的变型中,由此将超声波直接施加到化合物和通过颊膜输注化合物的部位,化合物可以放置在输送装置内。 在一个变化中,超声波可以通过与化合物和膜的直接相互作用来控制释放,而且还可以通过递送装置控制释放。 在另一个实施例中,递送装置有助于调节释放和输注速率。 化合物还可以与改变颊膜渗透性的化学试剂组合施用,由此帮助化合物输注到循环系统中。
    • 132. 发明授权
    • System for delayed and pulsed release of biologically active substances
    • 延迟和脉冲释放生物活性物质的系统
    • US4921757A
    • 1990-05-01
    • US92554
    • 1987-09-03
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • A61K9/127A61K9/50A61K9/70
    • A61K9/703A61K9/127A61K9/5026A61K9/5031A61K9/7084Y10S436/829Y10S514/963Y10S514/965Y10T428/2984
    • A system for controlled release both in vivo and in vitro of entrapped substances, either at a constant rate over a period of time or in discrete pulses, is disclosed. Biologically active substances, such as drugs, hormones, enzymes, genetic material, antigens including viruses, vaccines, or inorganic material such as dyes and nutrients, are entrapped in liposomes which are protected from the biological environment by encapsulation within semi-permeable microcapsules or a permeable polymeric matrix. Release of the entrapped substance into the surrounding environment is governed by the permeability of both the liposome and surrounding matrix to the substance. Permeability of the liposome is engineered by modifying the composition and method for making the liposomes, thereby producing liposomes which are sensitive to a specific stimuli such as temperature, pH, or light; or by including a phospholipase within some or all of the liposomes or the surrounding matrix; or by destabilizing the liposome to break down over a period of time; or by any combination of these features.
    • 公开了一种在一段时间内或以离散脉冲以恒定速率在体内和体外捕获的物质的系统。 诸如药物,激素,酶,遗传物质,包括病毒的抗原,疫苗或诸如染料和营养素的无机材料的生物活性物质被包埋在通过包封在半渗透性微胶囊内的生物环境中保护的脂质体中 可渗透聚合物基体。 被截留的物质释放到周围环境中由脂质体和周围基质对物质的渗透性决定。 通过改变制备脂质体的组合物和方法来改进脂质体的渗透性,从而产生对特定刺激如温度,pH或光敏感的脂质体; 或通过在一些或全部脂质体或周围基质中包含磷脂酶; 或通过不稳定脂质体在一段时间内分解; 或通过这些特征的任意组合。
    • 133. 发明授权
    • Biodegradable polymeric drug delivery system with adjuvant activity
    • 具有佐剂活性的可生物降解聚合物药物递送系统
    • US4863735A
    • 1989-09-05
    • US914380
    • 1986-10-02
    • Joachim B. KohnRobert S. LangerSteven M. NiemiJames G. Fox
    • Joachim B. KohnRobert S. LangerSteven M. NiemiJames G. Fox
    • A61K9/22A61K39/39A61K47/48C08G69/10
    • C08G69/10A61K39/39A61K47/48192A61K2039/55516A61K2039/55555A61K2039/55566Y10S514/885Y10S514/953Y10S514/963Y10S514/964Y10S514/965
    • An antigen delivery system utilizing a biodegradable polymer with good mechanical properties in combination with a material stimulating the immune system. The material having adjuvant activity may be polymer degradation products or an adjuvant which is contained within or bound to the polymer. In one embodiment, the polymer is formed from tyrosine dipeptides. Poly(CTTH-iminocarbonate) is a preferred tyrosine dipeptide polymer for constructing implantable delivery systems for antigenic material. The polymer is not an adjuvant in itself but degrades into products which stimulate the immune system. The tyrosine dipeptide can also be used as a conventional adjuvant. The advantages of the system are that a polymer can be used to form a biodegradable integral structure which is useful as both an implantable source of an antigen or other biologically active compound and as a control means for the rate of release of the biologically active compound, wherein the result is sustained, relatively constant delivery of antigen with simultaneous stimulation of the immune response.
    • 使用具有良好机械性能的生物可降解聚合物与刺激免疫系统的材料组合的抗原递送系统。 具有佐剂活性的材料可以是聚合物降解产物或包含在聚合物内或与聚合物结合的佐剂。 在一个实施方案中,聚合物由酪氨酸二肽形成。 聚(CTTH-亚氨基碳酸酯)是用于构建用于抗原材料的可植入递送系统的优选的酪氨酸二肽聚合物。 聚合物本身不是佐剂,但会降解成刺激免疫系统的产物。 酪氨酸二肽也可以用作常规佐剂。 该系统的优点是可以使用聚合物形成可生物降解的整体结构,其可用作抗原的可植入源或其它生物活性化合物,并且作为生物活性化合物的释放速率的对照手段, 其中所述结果是持续的,相对恒定的抗原递送,同时刺激免疫应答。
    • 134. 发明授权
    • Extracorporeal reactors containing immobilized species
    • 含有固定化物种的体外反应堆
    • US4863611A
    • 1989-09-05
    • US44245
    • 1987-04-30
    • Howard BernsteinMargaret A. WheatleyRobert S. Langer
    • Howard BernsteinMargaret A. WheatleyRobert S. Langer
    • A61M1/36B01D15/02B01J20/32
    • B01D15/02A61M1/3675B01J20/321B01J20/3212B01J20/3274
    • An apparatus for removing material from a biological solution consisting of a reactor chamber having an inlet and an outlet, a bioactive compound immobilized on particular supports within the reactor, means for retaining the particular supports within the reactor, means for recirculating the solution and the supports at a high flow rate within the reactor, and means for agitating or dispersing the recirculating solution-support mixture throughout the reactor chamber so as to prevent packing of the supports while not subjecting the solution to excessive or damaging forces.In the given example, an apparatus for the extracorporeal removal of heparin from blood is provided. Heparinase is immobilized on cross-linked agarose beads recirculated at a high flow rate through the reactor. Agitation of the blood-bead mixture sufficient to prevent packing of the beads within the reactor chamber is provided by means of a series of openings in the recirculation tube dispersing the mixture throughout the chamber.
    • 用于从由具有入口和出口的反应器室组成的生物溶液中去除材料的装置,固定在反应器内的特定载体上的生物活性化合物,用于将特定载体保持在反应器内的装置,用于将溶液和载体 反应器内的高流速,以及用于搅拌或分散循环溶液 - 载体混合物到整个反应器室的装置,以防止支撑物的包装,同时不使溶液经受过度或破坏的力。 在给出的实施例中,提供了用于从血液中体外去除肝素的装置。 肝素酶固定在通过反应器以高流速再循环的交联琼脂糖珠上。 借助于将混合物分散在整个室中的循环管中的一系列开口提供足以防止珠在反应器室内堆积的血珠混合物的搅动。